Breast Feeding — Investigation of Breastfeeding Protection Against Infant Infections and Childhood Diseases
Citation(s)
Altunkan S, Ilman N, Kayatürk N, Altunkan E Validation of the Omron M6 (HEM-7001-E) upper-arm blood pressure measuring device according to the International Protocol in adults and obese adults. Blood Press Monit. 2007 Aug;12(4):219-25.
American Academy of Pediatrics Nutrition and Immunitiy. Chapter 31. In: Pediatric Nutriton Handbook CD- ROM. 4 th ed. Elk Growe Village: Abbott Laboratories, 1998: 473-84.
Coleman A, Freeman P, Steel S, Shennan A Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006 Feb;11(1):27-32.
Gökçay G, Garibagaoglu M Saglikli Çocugun Beslenmesi. Içinde: Neyzi O, Ertugrul T: Pediatri. 1. Cilt. Istanbul: Nobel Tip Kitabevi, 2002: 183-202.
Gökçay G, Garipagaoglu M Çocukluk ve Ergenlik Döneminde Beslenme. Istanbul: Saga Yayinlari, 2002: 24-63.
Lawrens RA, Lawrence RM Host-resistance factors and immunologic significance of human milk. In: Lawrens RA, Lawrence RM (eds). Breastfeeding. St. Louis: Mosby, 1994: 159-95.
Mazicioglu MM Büyüme gelisme izleminde kullanilan antropometrik ölçüm yöntemleri: Büyüme takibinin metodolojisi.Türkiye Aile Hekimligi Dergisi 2011;15(3):101-108.
Stuebe A The risks of not breastfeeding for mothers and infants. Rev Obstet Gynecol. 2009 Fall;2(4):222-31.
T C. Saglik Bakanligi, Hacettepe Üniversitesi Nüfus Etüdleri Enstitüsü. Türkiye Nüfus ve Saglik Arastirmasi 2003. Ankara: Macro International Inc, 2003.
Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit. 2006 Jun;11(3):165-71.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
